Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Kidney Int. 2013 May 8;84(4):776–785. doi: 10.1038/ki.2013.150

Figure 5.

Figure 5

Half-life of recombinant human FGF23 in animals with AKI or control mice. Left panel shows hFGF23 levels at different time points after IV rhFGF23 injection. Right panel shows percent remaining of the initial value. N=3 ctl, N=5 AKI, *p<0.05 compared with vehicle-injected mice.